<DOC>
	<DOCNO>NCT01030185</DOCNO>
	<brief_summary>To investigate safety performance Automated Fluid Shunt patient ascites diuretic resistance . Study Size Duration The primary study population include 40 patient enrol implanted NovaShunt Automated Fluid Shunt ( AFS ) 15 center Europe .</brief_summary>
	<brief_title>Safety Performance Automated Fluid Shunt Patients With Ascites Diuretic Resistance</brief_title>
	<detailed_description />
	<mesh_term>Ascites</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<criteria>Patients ≥ 18 year age Recurrence ascites define clinical reappearance ascites within 4 week initial paracentesis . Cirrhosis etiology Failure respond maximum 160 mg/d furosemide 400 mg/d spironolactone ( equivalent dos loopacting distalacting diuretic ) , intolerance high dose diuretic hyponatremia , hyperkalemia , sideeffects Dietary sodium restriction &lt; 88mEq/d . Serum creatinine level ≤ 2.0 mg/dL least 7 day study entry . Total bilirubin level less 3 mg/dL . Expected survival great 6 month Written inform consent Ability comply study procedure ability operate device . Women childbearing age use adequate contraceptive Presence recur systemic local infection , peritonitis , urinary tract infection , abdominal skin infection . Presence peritoneal carcinomatosis Advanced hepatocellular carcinoma , demonstrate : 1 . One tumor &gt; 5 cm diameter 2 . 3 nodule &gt; 3 cm diameter 3 . Portal thrombosis Other evidence malignant Etiology Ascites Evidence extensive ascites loculation Gastrointestinal hemorrhage due portal hypertension 2 week prior inclusion study . Hepatic encephalopathy two week prior implant Presence TIPS surgical portosystemic shunt Presence BuddChiari syndrome Previous liver transplant Obstructive uropathy Coagulopathy could correct prothrombin time INR &lt; 1.8 , Thrombocytopenia could correct platelet count great 60,000/mm3 Any clinically significant disease could adversely affect study participation judge Investigator Any condition require emergency treatment Pregnancy Patients another clinical study reach primary endpoint yet</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>ascites</keyword>
	<keyword>liver cirrhosis</keyword>
</DOC>